PRIOR AUTHORIZATION BURDENS - FLASCO

22
PRIOR AUTHORIZATION BURDENS FLASCO NOVEMBER 9, 2019 Risë Marie Cleland [email protected] www.Oplinc.com

Transcript of PRIOR AUTHORIZATION BURDENS - FLASCO

Page 1: PRIOR AUTHORIZATION BURDENS - FLASCO

PRIOR AUTHORIZATION BURDENS

FLASCO NOVEMBER 9, 2019

Risë Marie [email protected]

Page 2: PRIOR AUTHORIZATION BURDENS - FLASCO

2

Important to RememberThe information provided in this presentation is for informational purposes only. Information is provided for reference only and is not intended to provide reimbursement or legal advice.

Laws, regulations, and policies concerning reimbursement are complex and are updated frequently and should be verified by the user. Please consult your legal counsel or reimbursement specialist for any reimbursement or billing questions.

You are responsible for ensuring that you appropriately and correctly bill and code for any services for which you seek payment. Oplinc does not guarantee the timeliness or appropriateness of the information contained herein for your particular use.

Page 3: PRIOR AUTHORIZATION BURDENS - FLASCO

3

AGENDA§ Prior Authorization (PA) Challenges & Burdens§ Legislative Initiatives§ Facilitating & Streamlining the PA Process • Technology• Staffing• Workflow

Page 4: PRIOR AUTHORIZATION BURDENS - FLASCO

4

2018 AMA Prior Authorization (PA)Physician Survey

§ The AMA conducted a web-based survey administered in Dec. 2018§ Sample of 1000 practicing physicians• 40% primary care• 60% specialists

§ Survey findings increasing PA demands

Page 5: PRIOR AUTHORIZATION BURDENS - FLASCO

Increased significantly Increased somewhat No change Decreased somewhat or signifcantly

AMA Survey: How has the number of PAs changed in the last 5 years?

Source: American Medical Association - 2018 Prior Authorization Survey – Figures have been rounded

41%

46%

13%

1%

Medical services

Page 6: PRIOR AUTHORIZATION BURDENS - FLASCO

Abandoned treatment associated with PAQ. How often do issues related to the PA process lead to patients abandoning their recommended course of treatment?

75% report that PA can lead toTreatment abandonment

Source: American Medical Association - 2018 Prior Authorization Survey – Figures have been rounded

Page 7: PRIOR AUTHORIZATION BURDENS - FLASCO

Care delays associated with PAQ. For those patients whose treatment requires PA, how often

does this process delay access to necessary care?

91% Report care delays

%

%

%

%

Source: American Medical Association - 2018 Prior Authorization Survey – Figures have been rounded

Page 8: PRIOR AUTHORIZATION BURDENS - FLASCO

Physician perspective on PA burdensQ. How would you describe the burden associated with PA in your practice?

Source: American Medical Association - 2018 Prior Authorization Survey – Figures have been rounded

Page 9: PRIOR AUTHORIZATION BURDENS - FLASCO

9

Legislative InitiativesStates are passing prior authorization legislation to improve transparency and lessen the administrative burden www.ama-assn.org/sites/default/files/media-browser/public/arc-public/pa-state-chart.pdf

The AMA is working with states and specialty societies to enact legislation - AMA Model Bill – Sample State Legislation “Ensuring Transparency in Prior Authorization Act”www.ama-assn.org/sites/default/files/media-browser/specialty%20group/arc/model-bill-ensuring-transparency-in-prior-authorization.pdf

Page 10: PRIOR AUTHORIZATION BURDENS - FLASCO

Florida

State Law: HB221 - A health insurer or a PBM on behalf of the insurer, which does not have an ePA process for its contracted providers must use only the PA form approved by the Financial Services Commission. Signed into law 4/14/2016https://www.flsenate.gov/Session/Bill/2016/221

CS/HB 559: Prescription Drug Utilization Management Died in the House 5/3/2019https://www.flsenate.gov/Session/Bill/2019/559

SB 650: Health Insurer Authorization Died in the Senate 5/3/2019 https://www.flsenate.gov/Session/Bill/2019/650

Page 11: PRIOR AUTHORIZATION BURDENS - FLASCO

11

Florida State Law – Prior authorization627.42392 Prior authorization.—

(1) As used in this section, the term “health insurer” means an authorized insurer offering health insurance as defined in s. 624.603, a managed care plan as defined in s. 409.962(10), or a health maintenance organization as defined in s. 641.19(12).

(2) Notwithstanding any other provision of law, effective January 1, 2017, or six (6) months after the effective date of the rule adopting the prior authorization form, whichever is later, a health insurer, or a pharmacy benefits manager on behalf of the health insurer, which does not provide an electronic prior authorization process for use by its contracted providers, shall only use the prior authorization form that has been approved by the Financial Services Commission for granting a prior authorization for a medical procedure, course of treatment, or prescription drug benefit. Such form may not exceed two pages in length, excluding any instructions or guiding documentation, and must include all clinical documentation necessary for the health insurer to make a decision. At a minimum, the form must include: (1) sufficient patient information to identify the member, date of birth, full name, and Health Plan ID number; (2) provider name, address and phone number; (3) the medical procedure, course of treatment, or prescription drug benefit being requested, including the medical reason therefor, and all services tried and failed; (4) any laboratory documentation required; and (5) an attestation that all information provided is true and accurate.

(3) The Financial Services Commission in consultation with the Agency for Health Care Administration shall adopt by rule guidelines for all prior authorization forms which ensure the general uniformity of such forms.

(4) Electronic prior authorization approvals do not preclude benefit verification or medical review by the insurer under either the medical or pharmacy benefits.

History.—ss. 3, 4, ch. 2016-222; s. 16, ch. 2016-224; s. 40, ch. 2017-3.

Page 12: PRIOR AUTHORIZATION BURDENS - FLASCO

Kentucky

SB54 (passed March 26, 2019), requires that a process for electronically transmitting PA requests for drugs by providers must be developed by January 1, 2020. E-Prescribing software displaying information regarding a payer's formulary, payments, or benefit plan must be updated at least quarterly. A health insurer must provide a utilization review decision concerning urgent health care services within 24 hours after obtaining all necessary information to make the utilization review. Utilization review decisions concerning non-urgent health care services must be provided within 72 hours of obtaining all necessary information. Does not apply to contracts providing Medicaid benefits. Requires that decisions relating to utilization reviews are conducted by physicians of the same specialty as the ordering provider; to establish a time frame for providing utilization decisions; to allow for electronic format of certain required notices; to establish that an insurer's failure to respond within set time frames shall be deemed a prior authorization

https://apps.legislature.ky.gov/record/19RS/sb54.html#actions

Page 13: PRIOR AUTHORIZATION BURDENS - FLASCO

13

"Improving Seniors' Timely Access to Care Act of 2019Ӥ Create an electronic prior authorization program including the electronic transmission of prior

authorization requests and responses and a real-time process for items and services that are routinely approved;

§ Improve transparency by requiring plans to report to CMS on the extent of their use of prior authorization and the rate of approvals or denials;

§ Require plans to adopt transparent prior authorization programs that are reviewed annually, adhere to evidence-based medical guidelines, and include continuity of care for individuals transitioning between coverage policies to minimize any disruption in care;

§ Hold plans accountable for making timely prior authorization determinations and to provide rationales for denials; and

§ Prohibit additional prior authorization for medically-necessary services performed during a surgical or invasive procedure that already received, or did not initially require, prior authorization.

Page 14: PRIOR AUTHORIZATION BURDENS - FLASCO

14

Consensus Statement Improving PA Process includes:

§ Selectively applying PA requirements by distinguishing PA applications based on factors such as provider performance, adherence to best medical practices, or contractual obligations;

§ Regularly reviewing the treatments that are subject to PA requirements and removing requirements that are no longer appropriate;

§ Bolstering communication among insurers, providers, and patients to minimize potential care delays and to ensure clarity about rationale and changes;

§ Protecting continuity of care for patients who are undergoing treatment when PA requirements, providers, or health insurers change; and

§ Improving automation to boost the efficacy of PA processes and requirements, such as by adopting national EHR standards for PA across the industry and making formulary information and coverage requirements more transparent at the point of care.

Signed by: American Medical Association (AMA), America’s Health Insurance Plans (AHIP), the Medical Group Management Association (MGMA), the American Pharmacists Association (APhA), and the Blue Cross Blue Shield

Association

Page 15: PRIOR AUTHORIZATION BURDENS - FLASCO

15

Technology§ PA tools in EHR/Practice Management Systems• Track PAs required, received

§ Online payer portals§ Decision support tools• Electronic PA system with regimen support program that interface w/EHR • Interface w/payers for real time PA

§ Cloud-based technologies - automatically adjudicate PA requests that meet payer’s payment and clinical care guidelines

Page 16: PRIOR AUTHORIZATION BURDENS - FLASCO

16

Policy Reporter§ Policy Reporter is a subscription service that provides access to live medical, diagnostic

and pharmaceutical policy updates, as they happen, across the entire U.S. health insurance landscape.

§ Subscribers can access an online application to check for updates, evaluate trends within payer policies, organize and sort policy information, and more.

https://www.policyreporter.com

Page 17: PRIOR AUTHORIZATION BURDENS - FLASCO

17

Facilitating & Streamlining the PA Process1. Ensure adequate staff dedicated to handle the PA process• Financial counselor/patient advocates, clinicians• Most oncology clinics employ at least 1 full time staff devoted to the PA

process2. PA staff coordinate and communicate with clinical staff to limit denials

due to treatment being received prior to obtaining a necessary PA3. Proactively enroll patient in patient-assistance program when

appropriate

Page 18: PRIOR AUTHORIZATION BURDENS - FLASCO

18

Identify Patients/Services Requiring PA§ Accurate patient demographics are key:• Insurer/plan information– Coverage, medical policy, PA requirements

§ Track denials due to incorrect demographics & take corrective action to process/policy where necessary

§ To minimize billing/collection problems• Limit the number of staff members who can initiate changes in an existing

patient’s demographics • Identify staff members who need to be notified of any changes made to

patient’s demographics

Page 19: PRIOR AUTHORIZATION BURDENS - FLASCO

19

Workflow - Treatment Plan§ Treatment plans are entered in EHR • Diagnoses, services/drugs ordered, dosage, frequency,

route of administration§ PA staff reviews treatment plan and reported

diagnoses for compliance with payer’s Medical Policy• FDA indications• NCCN guidelines• Compendia listings

§ If treatment plan does not meet PA guidelines clinical team is notified• Alternate treatment options may be explored at this point

Page 20: PRIOR AUTHORIZATION BURDENS - FLASCO

20

Workflow § PA staff identifies medical record documentation and supporting literature that supports medical

necessity of the service for that particular patient§ Diagnoses, all pertinent medical record documentation to support medical necessity i.e..

pathology, labs, prior treatments, staging etc.• Refer to clinical staff for guidance when appropriate

§ Maintain a file of all PA information to facilitate PA process:• PA requirements, documentation submitted, details of any phone calls, (include date/time of

submission or phone call, who you spoke with) and responses received.§ Follow-up on PA requests• Approvals are documented and treatment is approved• Denials may be appealed or clinician may change treatment

Page 21: PRIOR AUTHORIZATION BURDENS - FLASCO

5 TIPS FROM THE AMA1. Check PA requirements before providing services or sending prescriptions to the

pharmacy 2. Establish a protocol to consistently document data required for a PA in the

medical record - Uniformly follow a protocol to help avoid delays in patient therapy, prevent potential follow-ups with patients for additional information and minimize time spent on authorization.

3. Select the PA method that will be most efficient, given the particular situation and available options - PA methods include standard electronic transactions, health plan portals, fax, telephone and secure email. Select the method that best fits your practice to reduce work flow disruptions.

4. Regularly follow up to ensure timely PA approval - The PA process is still primarily manual and a request could be lost in one of the many steps. Track your requests, and follow up to prevent delays that can occur if information is lost or not received by payers.

5. When a PA is inappropriately denied, submit an organized, concise and well-articulated appeal with supporting clinical information - You can increase your chances of success in overturning a PA denial by making sure all clinical information is included with the appeal, including any data that may have been missing from the initial request. For prescription appeals, think about adopting electronic prior authorization technology to further streamline the process.

Page 22: PRIOR AUTHORIZATION BURDENS - FLASCO

22

ResourcesAMA Resources to Reduce PA Burdens

https://www.ama-assn.org/practice-management/addressing-prior-authorization-issues

Emily Carroll, AMA senior legislative [email protected]